Roger Vogel

1.6k total citations
38 papers, 1.2k citations indexed

About

Roger Vogel is a scholar working on Ophthalmology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Roger Vogel has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Ophthalmology, 7 papers in Pathology and Forensic Medicine and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Roger Vogel's work include Glaucoma and retinal disorders (21 papers), Ocular Infections and Treatments (8 papers) and Retinal Diseases and Treatments (7 papers). Roger Vogel is often cited by papers focused on Glaucoma and retinal disorders (21 papers), Ocular Infections and Treatments (8 papers) and Retinal Diseases and Treatments (7 papers). Roger Vogel collaborates with scholars based in United States, United Kingdom and Sweden. Roger Vogel's co-authors include Franz Grehn, Peng T. Khaw, Gábor Holló, R P Wilson, Nathan L. Mata, R. S. Crockett, Lawrence J. Singerman, T. V. Bui, Jay B. Lichter and Yun Han and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Roger Vogel

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Vogel United States 18 832 409 397 222 85 38 1.2k
Marie Goldschild France 9 620 0.7× 522 1.3× 817 2.1× 47 0.2× 19 0.2× 9 1.1k
Kenneth Sall United States 20 908 1.1× 566 1.4× 1.3k 3.2× 204 0.9× 59 0.7× 41 1.8k
Andreas Katsanos Greece 26 1.6k 1.9× 876 2.1× 481 1.2× 201 0.9× 223 2.6× 105 1.9k
Thomas K. Mundorf United States 14 606 0.7× 420 1.0× 914 2.3× 30 0.1× 12 0.1× 24 1.2k
Minjie Sheng China 13 244 0.3× 240 0.6× 291 0.7× 126 0.6× 31 0.4× 25 634
Daniel Kook Germany 27 2.1k 2.6× 1.8k 4.5× 320 0.8× 346 1.6× 430 5.1× 72 2.6k
Andrea Maria Plateroti Italy 13 266 0.3× 189 0.5× 76 0.2× 114 0.5× 62 0.7× 23 558
Jinglin Yi China 17 242 0.3× 201 0.5× 81 0.2× 311 1.4× 203 2.4× 43 803
R. C. Andrew Symons Australia 17 343 0.4× 197 0.5× 51 0.1× 289 1.3× 39 0.5× 50 828
Yo‐Chen Chang Taiwan 17 401 0.5× 297 0.7× 36 0.1× 194 0.9× 50 0.6× 53 763

Countries citing papers authored by Roger Vogel

Since Specialization
Citations

This map shows the geographic impact of Roger Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Vogel more than expected).

Fields of papers citing papers by Roger Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Vogel. The network helps show where Roger Vogel may publish in the future.

Co-authorship network of co-authors of Roger Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Vogel. A scholar is included among the top collaborators of Roger Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Vogel. Roger Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novack, Gary D., Richard A. Lewis, Roger Vogel, et al.. (2013). Randomized, Double-Masked, Placebo-Controlled Study to Assess the Ocular Safety of Mirabegron in Healthy Volunteers. Journal of Ocular Pharmacology and Therapeutics. 29(7). 674–680. 25 indexed citations
2.
Mata, Nathan L., Jay B. Lichter, Roger Vogel, et al.. (2012). INVESTIGATION OF ORAL FENRETINIDE FOR TREATMENT OF GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION. Retina. 33(3). 498–507. 130 indexed citations
3.
Foster, C. Stephen, et al.. (2010). Durezol ® (Difluprednate Ophthalmic Emulsion 0.05%) Compared with Pred Forte ® 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis. Journal of Ocular Pharmacology and Therapeutics. 26(5). 475–483. 65 indexed citations
4.
Mata, Nathan L. & Roger Vogel. (2010). Pharmacologic treatment of atrophic age-related macular degeneration. Current Opinion in Ophthalmology. 21(3). 190–196. 16 indexed citations
5.
Vogel, Roger, et al.. (2010). Demonstration of Efficacy in the Treatment of Dry Eye Disease with 0.18% Sodium Hyaluronate Ophthalmic Solution (Vismed, Rejena). American Journal of Ophthalmology. 149(4). 594–601. 54 indexed citations
6.
Vogel, Roger, et al.. (2009). A Phase II, Double-Masked, Placebo-Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects with Age-Related Macular Degeneration: Baseline Lesion Size, Characteristics, and Preliminary Progression Data. Investigative Ophthalmology & Visual Science. 50(13). 4919–4919. 3 indexed citations
7.
Korenfeld, Michael, Steven Silverstein, David L. Cooke, Roger Vogel, & R. S. Crockett. (2008). Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. Journal of Cataract & Refractive Surgery. 35(1). 26–34. 82 indexed citations
8.
Pflugfelder, Stephen C., Steven L. Maskin, Bruce D. Anderson, et al.. (2004). A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. American Journal of Ophthalmology. 138(3). 444–457. 178 indexed citations
9.
Romanowski, Eric G., S P Bartels, Roger Vogel, et al.. (2004). Feasibility of an antiviral clinical trial requiring cross-country shipment of conjunctival adenovirus cultures and recovery of infectious virus. Current Eye Research. 29(2-3). 195–199. 2 indexed citations
10.
Vogel, Roger, Ellen R. Strahlman, & Kay D. Rittenhouse. (1999). Adverse Events Associated with Commonly Used Glaucoma Drugs. International Ophthalmology Clinics. 39(2). 107–124. 11 indexed citations
11.
Strahlman, Ellen R., et al.. (1996). A Six-week Dose-response Study of the Ocular Hypotensive Effect of Dorzolamide With a One-year Extension. American Journal of Ophthalmology. 122(2). 183–194. 63 indexed citations
12.
Ellwein, Leon B., D. Bruce Burlington, Carl Kupfer, et al.. (1994). The Eye Care Technology Forum. Ophthalmology. 101(1). 199–201.
13.
Wittreich, Johanna, Thomas J. Cook, Roger Vogel, et al.. (1992). The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. Eye. 6(1). 111–114. 17 indexed citations
14.
Vogel, Roger, et al.. (1992). Topically Administered Norfloxacin Compared with Topically Administered Gentamicin for the Treatment of External Ocular Bacterial Infections. American Journal of Ophthalmology. 113(6). 638–644. 16 indexed citations
15.
Vogel, Roger, et al.. (1992). Effect of Timolol versus Pilocarpine on Visual Field Progression in Patients with Primary Open-angle Glaucoma. Ophthalmology. 99(10). 1505–1511. 17 indexed citations
16.
Vogel, Roger. (1990). The effect of a gelrite vehicle on the efficacy of low concentration of timolol. Investigative Ophthalmology & Visual Science. 31. 404. 4 indexed citations
17.
Vogel, Roger, et al.. (1990). The Effect of Timolol, Betaxolol, and Placebo on Corneal Sensitivity in Healthy Volunteers. Journal of Ocular Pharmacology and Therapeutics. 6(2). 85–90. 9 indexed citations
18.
Vogel, Roger. (1989). Changing Therapy From Timolol to Betaxolol. Archives of Ophthalmology. 107(9). 1303–1303. 23 indexed citations
19.
20.
Vogel, Roger. (1989). Overview of efficacy and local tolerability of a new timolol/pilocarpine combination (summary). Survey of Ophthalmology. 33. 467–468. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Goldschild Breakdown of academic impact, for papers by Kenneth Sall Breakdown of academic impact, for papers by Andreas Katsanos Breakdown of academic impact, for papers by Thomas K. Mundorf Breakdown of academic impact, for papers by Minjie Sheng Breakdown of academic impact, for papers by Daniel Kook Breakdown of academic impact, for papers by Andrea Maria Plateroti Breakdown of academic impact, for papers by Jinglin Yi Breakdown of academic impact, for papers by R. C. Andrew Symons Breakdown of academic impact, for papers by Yo‐Chen Chang
Rankless by CCL
2026